Evotec SE (EVO) is lower by Monday morning, with the stock losing -0.81% in pre-market trading to 7.37. EVO's short-term technical score of 36 indicates that the stock has traded less bullishly over the last month than 64% of stocks on the market. In the Drug Manufacturers - Specialty & Generic industry, which ranks 92 out of 146 industries, the stock ranks higher than 46% of stocks. Evotec SE has fallen 1.72% over the past month, closing at $7.63 on February 26. During this period of time, the stock fell as low as $6.89 and as high as $7.74. EVO has an average analyst recommendation of Strong Buy. The company has an average price target of $15.60.
EVO has an Overall Score of 47. Find out what this means to you and get the rest of the rankings on EVO!